Stock Quote

Bristol-Myers Squibb Company (BMY.N) (New York Stock Exchange)
As of  23 Nov 2009
25.05USD
Price Change
+0.59
Percent Change
+2.41%
 
$25.05
23 Nov 2009
+2.41%
$24.46
$24.58
5,985,700
$25.10
$24.51
$24.63
$17.23
0.71
17,545,882

Research Another Stock: Symbol Look-up
Healthcare Stocks: Safe and Speculative
12:56pm EST(The Street) 
Rocket Stocks for the Week
9:20am EST(The Street) 
Jim Cramer's Portfolios of the Week
Friday, 20 Nov 2009 08:18am EST(The Street) 
Competition in Blood-Thinners: Win-Win for Everyone Involved
Friday, 20 Nov 2009 02:21am EST(Seeking Alpha) 
Big Pharma Under Pressure as Drug Patents Expire and Pipeline Slows
Thursday, 19 Nov 2009 03:03pm EST(Seeking Alpha) 
 
Name Current Position Compensation
Cornelius, James Chairman of the Board, Chief Executive Officer 25,037,800
Andreotti, Lamberto President, Chief Operating Officer, Director 10,755,300
Huet, Jean-Marc Chief Financial Officer, Executive Vice President 3,944,560

Profile

Bristol-Myers Squibb Company (BMS) is engaged in the discovery, development, licensing, manufacturing, marketing, distribution and sale of pharmaceutical and nutritional products. The Company had two segments: Pharmaceuticals and Nutritionals. The Pharmaceuticals segment is made up of the global... Full Description

Company Address

Bristol-Myers Squibb Company
345 Park Avenue
New York   NY   10154
P: +1212.5464000
F: +1212.5464020

Analyst Research

Performance of Key Competitors

Company Price Change
Johnson & Johnson $62.69 +0.38
Pfizer Inc. $18.53 +0.17
GlaxoSmithKline plc £1,277.50 +24.00
  BMY.N Industry
P/E(TTM) 12.86 6.90
P/S(TTM) 2.29 1.54
ROI(TTM) 21.99 6.18
ROE(TTM) 27.47 9.32
Consensus Recommendation Hold
EPS Est. (Current Period) 0.53
EPS Est. (Current Year) 2.02
Total Revenue $5,487.00M
Net Income $1,290.00M
EPS $0.48